Topoisomerase II inhibitors, such as mitoxantrone, happen to be associated with the event of secondary acute myeloid leukemia and myelosuppression. General Therapy with mitoxantrone needs to be accompanied by near and Recurrent checking of hematologic and chemical laboratory parameters, as well as Regular client observation. Convey to your Health care https://sandrah544csh3.wikigdia.com/user